| Sun, Dec 6, 2009 | | | Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability PR Newswire (Sun 10:30am)
| | Fri, Dec 4, 2009 | | | Cramer's 'Mad Money' Recap: How to Play the Surprising Jobs Report (Update 1) at TheStreet.com (Fri, Dec 4)
| | | The Coming Week's Game Plan: Blood, Tech and Jeers at CNBC (Fri, Dec 4)
| | | Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference PR Newswire (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | | Coverage initiated on Onyx Pharma by Soleil Briefing.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | | S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders PR Newswire (Wed, Dec 2)
| | Wed, Nov 25, 2009 | | | Onyx Pharmaceuticals Announces December 2009 Investor Events PR Newswire (Wed, Nov 25)
| | Fri, Nov 20, 2009 | | | [$$] U.K. Watchdog Says Bayer's Nexavar Is Too Expensive at The Wall Street Journal Online (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | | [$$] Corporate Watch at The Wall Street Journal Online (Thu, Nov 19)
| | | UK health unit rejects Bayer drug as too expensive at MarketWatch (Thu, Nov 19)
| | Mon, Nov 16, 2009 | | | Onyx wraps up $276M Proteolix buy at bizjournals.com (Mon, Nov 16)
| | | ONYX PHARMACEUTICALS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements EDGAR Online (Mon, Nov 16)
| | | Onyx Pharmaceuticals Completes Acquisition of Proteolix, Inc. PR Newswire (Mon, Nov 16)
| | Thu, Nov 12, 2009 | | | Trading Outlook for ZymoGenetics Inc. Issued by StockPreacher.com GlobeNewswire (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | | Onyx Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference PR Newswire (Wed, Nov 11)
| | | Healthcare Guru Adds Selected Biotech, Pharma Stakes Indie Research (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | | Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib and ONX 0803 at 51st American Society of Hematology Annual Meeting PR Newswire (Tue, Nov 10)
| | | Blood Cancer Meeting Abstracts Released: BioBuzz at TheStreet.com (Tue, Nov 10)
| | | Bristol Licenses Arthritis Drug: BioBuzz at TheStreet.com (Tue, Nov 10)
| | | Celgene in ASH Abstract Spotlight: BioBuzz at TheStreet.com (Tue, Nov 10)
| Add ONXX News to My Yahoo!:

| |
|